EXOSC8 Antikörper (AA 35-276)
Kurzübersicht für EXOSC8 Antikörper (AA 35-276) (ABIN7569224)
Target
Alle EXOSC8 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 35-276
-
Verwendungszweck
- Anti-Human EXOSC8 Polyclonal Antibody
-
Aufreinigung
- Antigen affinity purification.
-
Immunogen
- E. coli - derived recombinant Human EXOSC8 (Thr35-Lys276).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
-
-
- EXOSC8 (Exosome Component 8 (EXOSC8))
-
Andere Bezeichnung
- EXOSC8
-
Hintergrund
- Exosome component 8, EXOSC8, OIP-2, Opa-interacting protein 2, Exosome complex component RRP43, Ribosomal RNA-processing protein 43, OIP2, RRP43, p9
-
UniProt
- Q96B26
-
Pathways
- SARS-CoV-2 Protein Interaktom
Target
-